A new blood test could replace the brain scans and spinal taps currently used to diagnose Alzheimer's disease.

The research found that mice with Alzheimer's disease symptoms improved when a certain brain protein was suppressed.

During the Jan. 28 Alzheimer's Drug Discover Foundation lecture, panelists said the tests will revolutionize diagnosis and ...

Add Yahoo as a preferred source to see more of our stories on Google. Dr Michael Sandberg, whose mother had Alzheimer's disease, took part in the trial [BBC] An international trial is examining ...

The increased size of, and lesser blood supply to, a key brain structure in patients with long COVID tracks with known blood ...

Diagnosing Alzheimer’s, a neurodegenerative disease, is complicated and costly. A study in RI could help speed up the process ...

Imagine diagnosing one of the most challenging neurological diseases with just a quick finger-prick, a few drops of blood and ...

Topeka's Cotton O'Neil is using a new, early diagnosis tool to test new Alzheimer's treatments.

Researchers are examining whether samples collected show accurately certain biomarkers which denote abnormal proteins in the brain. Volunteers in the ongoing study undergo cognitive tests, an MRI and ...

Researchers connecting pieces of the massive Alzheimer's puzzle are closer to slotting the next one in place, with yet ...

The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...